The global medical oxygen concentrators market size was valued at USD 1.54 billion in 2025 and is projected to grow from USD 1.68 billion in 2026 to USD 3.35 billion by 2034, registering a CAGR of 9.01% during the forecast period from 2026 to 2034. North America dominated the medical oxygen concentrators market with a market share of 38.5% in 2025.
Medical oxygen concentrators are electrically powered medical devices that extract oxygen from ambient air and deliver a concentrated supply of oxygen to patients requiring supplemental oxygen therapy. They use technologies such as molecular sieve adsorption to separate nitrogen from oxygen and provide continuous or pulse-dose oxygen delivery. These devices are commonly used in hospitals, clinics, emergency care, and home healthcare settings for patients with respiratory conditions.
Download a Free Sample To learn more about this report,
Growing Adoption of Portable and Energy-Efficient Oxygen Concentrators
The medical oxygen concentrators market trends are being driven by the growing need for home-based respiratory care, increasing cases of chronic respiratory diseases, and advances in portable oxygen delivery technologies. Hospitals, clinics, and home healthcare providers are increasingly using oxygen concentrators because they can generate medical oxygen from surrounding air without requiring frequent replacement of compressed oxygen cylinders. Portable oxygen concentrators are gaining attention among patients who need greater mobility, while newer stationary models are being designed for continuous home use with improved energy efficiency and lower operating noise. Manufacturers are also integrating digital displays, oxygen concentration monitoring, battery systems, and remote connectivity to improve device safety and usability. The expansion of home healthcare services and improved access to respiratory care in developing regions are further supporting demand for reliable oxygen therapy equipment.
These developments indicate that portable oxygen therapy, energy-efficient designs, connected monitoring, and home-based respiratory care will remain the key medical oxygen concentrators market trends, improving patient mobility, supporting reliable oxygen delivery, and driving long-term growth across respiratory healthcare applications.
Rising Prevalence of Respiratory Disorders and Growing Home Healthcare Adoption
The medical oxygen concentrators market is expanding due to the increasing prevalence of respiratory disorders such as chronic obstructive pulmonary disease, asthma, and other conditions requiring supplemental oxygen therapy. Growing demand for home-based healthcare and portable oxygen therapy is encouraging patients and healthcare providers to adopt oxygen concentrators as convenient alternatives to traditional oxygen cylinders. Rising healthcare expenditure, aging populations, and improvements in oxygen concentrator technology are further supporting adoption. These developments are significantly contributing to medical oxygen concentrators market growth as healthcare systems increasingly emphasize accessible and continuous respiratory care.
High Device Costs and Dependence on Electricity
The medical oxygen concentrators market faces challenges due to the relatively high cost of advanced portable devices and their dependence on reliable electricity supplies. Patients in low-income and remote regions may face difficulties accessing oxygen concentrators because of limited healthcare infrastructure, unstable power networks, and affordability concerns. In addition, regular maintenance, filter replacement, and servicing requirements can increase the total cost of ownership. Recent medical oxygen concentrators market analysis indicates that these factors continue to restrict adoption in resource-constrained healthcare settings.
Expansion of Portable Oxygen Therapy and Connected Respiratory Care
The medical oxygen concentrators market is expected to benefit from increasing demand for portable oxygen therapy, remote patient monitoring, and connected respiratory care technologies. Manufacturers are developing compact concentrators with improved battery performance, oxygen purity monitoring, and digital connectivity to support greater patient mobility and treatment adherence. Growing investments in home healthcare infrastructure and respiratory disease management are also creating significant growth opportunities. These developments are expected to strengthen the medical oxygen concentrators market size by expanding access to oxygen therapy across home and ambulatory care settings.
Maintaining Oxygen Purity and Ensuring Reliable Device Performance
The medical oxygen concentrators market continues to face challenges related to maintaining consistent oxygen concentration, ensuring device reliability, and meeting evolving medical device safety standards. Manufacturers must improve filtration systems, compressor durability, noise performance, and energy efficiency while ensuring uninterrupted oxygen delivery for patients requiring continuous therapy. Supply chain disruptions and the need for trained technical support also add operational complexity. According to recent medical oxygen concentrators market reports, companies are investing in advanced sensor technologies, remote monitoring capabilities, and energy-efficient designs to improve device reliability and support long-term respiratory care.
Portable Segment is Projected to Register the Fastest Growth at a CAGR of 7.65%
The portable segment is projected to register the fastest growth at a CAGR of 7.65% during 2026–2034. In 2025, the segment accounted for 57.6% of the global medical oxygen concentrators market, with a value of USD 0.89 billion. Growth is driven by increasing demand for convenient oxygen therapy, rising preference for home-based care, and the growing adoption of lightweight and easily transportable oxygen concentrators. Increasing prevalence of respiratory disorders and greater patient mobility continue to support the segment's growth.
The stationary segment continues to maintain a significant market presence owing to its high oxygen output capacity, reliable continuous operation, and widespread use in homecare and healthcare facilities. Its suitability for patients requiring long-duration oxygen therapy continues to support steady demand.
Request Customizationto receive a tailored report.
Pulse Flow Segment is Projected to Register the Fastest Growth at a CAGR of 7.75%
The pulse flow segment is projected to register the fastest growth at a CAGR of 7.75% during 2026–2034. In 2025, the segment accounted for 38.2% of the global medical oxygen concentrators market, with a value of USD 0.59 billion. Growth is driven by increasing demand for portable oxygen therapy, improved battery efficiency, and growing preference for oxygen delivery systems that support greater patient mobility. Technological advancements in compact oxygen concentrators continue to support the segment's growth.
The continuous flow segment dominated the market owing to its ability to provide a consistent supply of oxygen and its extensive use among patients requiring continuous oxygen therapy. Increasing adoption across hospitals and homecare settings, along with the growing prevalence of chronic respiratory diseases, continues to reinforce the segment's leading market position.
Home Care Settings Segment is Projected to Register the Fastest Growth at a CAGR of 7.55%
The home care settings segment is projected to register the fastest growth at a CAGR of 7.55% during 2026–2034. In 2025, the segment accounted for 49.3% of the global medical oxygen concentrators market, with a value of USD 0.76 billion. Growth is driven by increasing preference for home-based oxygen therapy, rising prevalence of chronic respiratory diseases, and growing demand for portable and user-friendly oxygen delivery solutions. Expanding home healthcare services and improvements in remote patient care continue to support the segment's growth.
The hospitals segment continues to maintain a significant market presence owing to the high demand for oxygen therapy among hospitalized patients, particularly those requiring respiratory support. Ambulatory surgical centers continue to witness steady demand due to increasing outpatient procedures and the need for reliable oxygen supply during perioperative care, while other end users contribute to market growth through specialized healthcare and long-term care applications.
Speak to an Analystto discuss market opportunities.
North America medical oxygen concentrators market accounted for 38.5% of the global market, reaching USD 0.59 billion in 2025, and is projected to grow at a CAGR of 6.45% during the forecast period. The market is driven by the increasing prevalence of respiratory disorders, rising demand for home-based oxygen therapy, growing geriatric population, and increasing adoption of portable oxygen concentrators. Continuous advancements in oxygen delivery technologies continue to support regional market growth.
The US market was valued at USD 0.50 billion in 2025, making it the largest contributor in North America. Increasing prevalence of chronic respiratory diseases, growing adoption of home healthcare, rising healthcare expenditure, and expanding demand for portable oxygen therapy solutions continue to drive market growth.
Canada's market reached USD 0.09 billion in 2025. Growing demand for home-based respiratory care, increasing healthcare investments, expanding adoption of portable medical devices, and rising awareness of oxygen therapy continue to support steady market expansion.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe medical oxygen concentrators market accounted for 27.2% of the global market, reaching USD 0.42 billion in 2025, and is projected to grow at a CAGR of 6.25% during the forecast period. Rising prevalence of respiratory diseases, increasing demand for home healthcare, expanding elderly population, and growing adoption of advanced oxygen therapy equipment continue to strengthen regional market growth. Healthcare infrastructure development and technological advancements further support market expansion.
The UK market was valued at USD 0.08 billion in 2025. Increasing demand for home oxygen therapy, growing respiratory disease burden, expanding healthcare services, and rising adoption of portable oxygen concentrators continue to support market growth.
Germany market accounted for USD 0.12 billion in 2025. Strong healthcare infrastructure, increasing adoption of home-based respiratory care, growing elderly population, and rising investments in advanced medical equipment continue to drive market expansion.
Asia Pacific medical oxygen concentrators market accounted for 22.8% of the global market, reaching USD 0.35 billion in 2025, and is projected to grow at a CAGR of 8.15% during the forecast period. Rapid healthcare infrastructure development, increasing prevalence of respiratory disorders, growing healthcare awareness, and expanding access to home-based oxygen therapy continue to accelerate regional market growth. Rising healthcare expenditure and increasing demand for portable medical devices further strengthen market expansion.
China's market accounted for USD 0.15 billion in 2025, representing the largest share within Asia Pacific. Expanding healthcare infrastructure, increasing respiratory disease burden, growing adoption of home healthcare equipment, and rising investments in medical device manufacturing continue to drive market expansion.
Japan's market generated USD 0.06 billion in 2025. Increasing elderly population, growing prevalence of respiratory conditions, expanding home healthcare services, and rising demand for compact oxygen delivery systems continue to support market growth.
Latin America medical oxygen concentrators market accounted for 6.4% of the global market, reaching USD 0.10 billion in 2025, and is projected to grow at a CAGR of 6.7% during the forecast period. Increasing healthcare access, growing prevalence of respiratory diseases, expanding home healthcare services, and rising adoption of oxygen therapy equipment continue to support regional market growth.
Brazil market accounted for USD 0.06 billion in 2025. Increasing healthcare investments, growing demand for respiratory care, expanding access to home oxygen therapy, and rising adoption of portable medical equipment continue to support market expansion.
Middle East and Africa medical oxygen concentrators market accounted for 5.1% of the global market, totaling USD 0.08 billion in 2025, and is projected to grow at a CAGR of 6.55% during the forecast period. Increasing investments in healthcare infrastructure, growing prevalence of respiratory diseases, expanding access to oxygen therapy, and rising demand for home-based medical care continue to support regional market growth.
The UAE market was valued at USD 0.02 billion in 2025. Increasing investments in advanced healthcare facilities, expanding home healthcare services, growing demand for respiratory care, and rising adoption of portable oxygen concentrators continue to drive market growth.
Africa's market reached USD 0.06 billion in 2025. Expanding healthcare access, increasing investments in medical infrastructure, growing awareness of oxygen therapy, and rising demand for affordable respiratory care equipment continue to create long-term growth opportunities across the region.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Automated External Defibrillators Market Size, Share, Growth, 2034
Kyphoplasty Market Size, Share, Growth, Analysis, Report, 2034
Aerosol Delivery Devices Market Size, Share, Growth, 2034
Defibrillator Market Size, Share, Growth, Analysis, Report, 2034
Colorectal Cancer Screening Market Size, Share, Growth, 2034
Medical Implants Market Size, Share, Growth, Forecast, 2034
We are featured on:
sales@straitsresearch.com